Blueprint of quartz crystal microbalance biosensor for early detection of breast cancer through salivary autoantibodies against ATP6AP1

Biosensors and Bioelectronics

Volumn 65, Issue , 2015, Pages 62-70

  Arif, Sania ^a   Qudsia, Syeda ^a   Urooj, Samina ^a   Chaudry, Nazia ^a   Arshad, Aneeqa ^a   Andleeb, Saadia ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

ATP6AP1; Biosensor; Early detection of breast cancer through saliva; Piezoelectric; Salivary autoantibodies

Indexed keywords

ATP6AP1; AUTOANTIBODIES; EARLY DETECTION OF BREAST CANCER; PIEZOELECTRIC;

BIOSENSORS;

ATP6AP1 PROTEIN; AUTOANTIBODY; BRCA1 PROTEIN; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; SILICON DIOXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; ATP6AP1 PROTEIN, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANTIBODY TITER; BIOSENSOR; BREAST; BREAST BIOPSY; BREAST CANCER; CANCER PATIENT; CANCER SCREENING; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; MAMMOGRAPHY; NONHUMAN; PIEZOELECTRICITY; PROTEIN FUNCTION; QUARTZ CRYSTAL MICROBALANCE; REVIEW; SALIVA ANALYSIS; SEROLOGY; SIGNAL TRANSDUCTION; ANIMAL; BREAST NEOPLASMS; DEVICES; EARLY CANCER DIAGNOSIS; FEMALE; GENETIC PROCEDURES; HUMAN; IMMUNOLOGY; PATHOLOGY; PROCEDURES; SALIVA;

ANIMALS; AUTOANTIBODIES; BIOSENSING TECHNIQUES; BREAST; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; QUARTZ CRYSTAL MICROBALANCE TECHNIQUES; SALIVA; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84908688932     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.09.088     Document Type: Review

References (110)

1. Agha-Hosseini F., Mirzaii-Dizgah I., Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med. Oral Patol. Oral y Cir. Bucal 2009, 14(10):e521-e524.
2. Altintas Z., Uludag Y., Gurbuz Y., Tothill I.E. Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen. Talanta 2011, 86(0):377-383.
3. Anderson J.D. Breast feeding and breast-cancer. S. Afr. Med. J. 1975, 49(13):479-482.
4. Anderson K.S., Sibani S., Wallstrom G., Qiu J., Mendoza E.A., Raphael J., Hainsworth E., Montor W.R., Wong J., Park J.G., Lokko N., Logvinenko T., Ramachandran N., Godwin A.K., Marks J., Engstrom P., LaBaer J. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J. Proteome Res. 2010, 10(1):85-96.
5. Archibald D.W., Zon L., Groopman J.E., McLane M.F., Essex M. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Blood 1986, 67(3):831-834.
6. AshbeckE.L.,RosenbergR.D.,StauberP.M.,KeyC.R., 2007. Benign breast biopsy diagnosis and subsequent risk of breast cancer,Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(3), pp. 467-472.
7. Bailey S.L., Sigal B.M., Plevritis S.K. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. J. Natl. Cancer Inst. 2010, 102(16):1263-1271.
8. Bello A., Bianchi F., Careri M., Giannetto M., Mastria V., Mori G., Musci M. Potentialities of a modified QCM sensor for the detection of analytes interacting via H-bonding and application to the determination of ethanol in bread. Sens. Actuators B: Chem. 2007, 125(1):321-325.
9. Berkey C.S., Tamimi R.M., Rosner B., Frazier A.L., Colditz G.A. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer: Am. Cancer Soc. 2012, 118(11):2796-2803.
10. Bohunicky B., Mousa S.A. Biosensors: the new wave in cancer diagnosis. Nanotechnol. Sci. Appl. 2011, 4:1-10.
11. Brandtzaeg P.E.R. Do salivary antibodies reliably reflect both mucosal and systemic immunity?. Ann. N. Y. Acad. Sci. 2007, 1098(1):288-311.
12. Brem R.F., Floerke A.C., Rapelyea J.A., Teal C., Kelly T., Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008, 247(3):651-657.
13. Brooks M.N., Wang J., Li Y., Zhang R., Elashoff D., Wong D.T. Salivary protein factors are elevated in breast cancer patients. Mol. Med. Rep. 2008, 1(3):375-378.
14. Bunde R.L., Jarvi E.J., Rosentreter J.J. Piezoelectric quartz crystal biosensors. Talanta 1998, 46(6):1223-1236.
15. Cabioglu N., Hunt K.K., Singletary S.E., Stephens T.W., Marcy S., Meric F., Ross M.I., Babiera G.V., Ames F.C., Kuerer H.M. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J. Am. College Surg. 2003, 196(3):354-364.
16. Capobianco J.A., Shih W.Y., Adams G.P., Shih W.-H. Label-free Her2 detection and dissociation constant assessment in diluted human serum using a longitudinal extension mode of a piezoelectric microcantilever sensor. Sens. Actuators B: Chem. 2011, 160(1):349-356.
17. Cardenosa G., Doudna C., Eklund G.W. Ductography of the breast: technique and findings. AJR. Am. J. Roentgenol. 1994, 162(5):1081-1087.
18. Carrascosa L.G., Calle A., Lechuga L.M. Label-free detection of DNA mutations by SPR: application to the early detection of inherited breast cancer. Anal. Bioanal. Chem. 2009, 393(4):1173-1182.
19. Ching K.H., Burbelo P.D., Gonzalez-Begne M., Roberts M.E., Coca A., Sanz I., Iadarola M.J. Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's syndrome. J. Dental Res. 2011, 90(4):445-449.
20. Choi S., Chae J. Reusable biosensors via in situ electrochemical surface regeneration in microfluidic applications. Biosens. Bioelectron. 2009, 25(2):527-531.
21. Chu K.C., Tarone R.E., Kessler L.G., Ries L.A., Hankey B.F., Miller B.A., Edwards B.K. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J. Natl. Cancer Inst. 1996, 88(21):1571-1579.
22. Cleary M.P., Grossmann M.E. Obesity and breast cancer: the estrogen connection. Endocrinology 2009, 150(6):2537-2542.
23. Culha M., Stokes D.L., Griffin G.D., Vo-Dinh T. Application of a miniature biochip using the molecular beacon probe in breast cancer gene BRCA1 detection. Biosens. Bioelectron. 2004, 19(9):1007-1012.
24. Dodd G.D. Present status of thermography, ultrasound and mammography in breast cancer detection. Cancer: Am. Cancer Soc. 1977, 39(6):2796-2805.
25. Dooley W. Ductal lavage, nipple aspiration, and ductoscopy for breast cancer diagnosis. Curr. Oncol. Rep. 2003, 5(1):63-65.
26. Dudas S.P., Chatterjee M., Tainsky M.A. Usage of cancer associated autoantibodies in the detection of disease. Cancer Biomark. 2009, 6(5):257-270.
27. Enriquez L., Listinsky J. Role of MRI in breast cancer management. Clev. Clin. J. Med. 2009, 76(9):525-532.
28. Friedman P.D., Swaminathan S.V., Herman K., Kalisher L. Breast MRI: the importance of bilateral imaging. Am. J. Roentgenol. 2006, 187(2):345-349.
29. George J.R., Fitchen J.H. Future applications of oral fluid specimen technology. Am. J. Med. 1997, 102(4A):21-25.
30. Gildorf J., McDonnell W.M. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide. Pediatr. Res. 1991, 29(5):420-423.
31. Gohring J.T., Dale P.S., Fan X. Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor. Sens. Actuators B: Chem. 2010, 146(1):226-230.
32. Graham-Rowe D. Risk analysis: a dense issue. Nature 2012, 485(7400):S60-S61.
33. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M.R., Hayes D.F., Bast R.C., American Society of Clinical O. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 2007, 25(33):5287-5312.
34. Hartmann L.C., Sellers T.A., Frost M.H., Lingle W.L., Degnim A.C., Ghosh K., Vierkant R.A., Maloney S.D., Pankratz V.S., Hillman D.W., Suman V.J., Johnson J., Blake C., Tlsty T., Vachon C.M., Melton L.J., Visscher D.W. Benign breast disease and the risk of breast cancer. N. Engl. J. Med. 2005, 353(3):229-237.
35. Hernandez A., Serrano-Bueno G., Perez-Castineira J.R., Serrano A. Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer. Curr. Pharmaceut. Des. 2012, 18(10):1383-1394.
36. Hodi F.S., Schmollinger J.C., Soiffer R.J., Salgia R., Lynch T., Ritz J., Alyea E.P., Yang J., Neuberg D., Mihm M., Dranoff G. ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction. Proc. Natil. Acad. Sci. U. S. A. 2002, 99(10):6919-6924.
37. Ikuno N., Mackay I.R., Jois J., Omagari K., Rowley M.J. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 2001, 16(12):1390-1394.
38. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA-Cancer J. Clin 2011, 61(2):69-90.
39. Jertborn M., Svennerholm A.M., Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 1986, 24(2):203-209.
40. Johnson A.M., Parry J.V., Best S.J., Smith A.M., de Silva M., Mortimer P.P. HIV surveillance by testing saliva. AIDS 1988, 2(5):369-371.
41. Johnson B.N., Mutharasan R. Sample preparation-free, real-time detection of microRNA in human serum using piezoelectric cantilever biosensors at attomole level. Anal. Chem. 2012, 84(23):10426-10436.
42. Jokerst J.V., Raamanathan A., Christodoulides N., Floriano P.N., Pollard A.A., Simmons G.W., Wong J., Gage C., Furmaga W.B., Redding S.W. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens. Bioelectron. 2009, 24(12):3622-3629.
43. Junaidi, I., 2012. Breast cancer claims 40,000 lives a year in Pakistan. Dawn News, 10. January 2012. http://www.dawn.com/news/686995/breast-cancer-claims-400000-lives-a-year-in-pakistan-2.
44. Kaufman E., Lamster I.B. The diagnostic applications of saliva-a review. Crit. Rev. Oral Biol. Med. 2002, 13(2):197-212.
45. Kilic T., Topkaya S.N., Ozkan Ariksoysal D., Ozsoz M., Ballar P., Erac Y., Gozen O. Electrochemical based detection of microRNA, mir21 in breast cancer cells. Bios. Bioelectron. 2012, 38(1):195-201.
46. Knutson D., Steiner E. Screening for breast cancer: current recommendations and future directions. Am. Fam. Phys. 2007, 75(11):1660-1666.
47. Kuhl C.K., Schrading S., Leutner C.C., Morakkabati-Spitz N., Wardelmann E., Fimmers R., Kuhn W., Schild H.H. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J. Clin. Oncol. 2005, 23(33):8469-8476.
48. Kuo, Y., 2002. Ovulation-monitoring electrical toothbrush. In: Patexia (Ed.). Google Patents, US.
49. Kurosawa S., Aizawa H., Park J.-W. Quartz crystal microbalance immunosensor for highly sensitive 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin detection in fly ash from municipal solid waste incinerators. Analyst 2005, 130(11):1495-1501.
50. Kwon H.Y., Nam E.J., Kim S.W., Kim Y.T. A young patient in Korea with Krukenberg tumors arising from breast cancer: a case report. Korean J. Obstet. Gynecol. 2011, 54(10):643-646.
51. L'Esperance S., Popa I., Bachvarova M., Plante M., Patten N., Wu L., Tetu B., Bachvarov D. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. Int. J. Oncol. 2006, 29(1):5-24.
52. LabaerJ.,AndersonK.S.,WallstromG.,SibaniS.,RamachandranN., 2013. Biomarkers for the early detection of breast cancer. Google Patents.
53. Lagadec C., Vlashi E., Della Donna L., Dekmezian C., Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells 2012, 30(5):833-844.
54. Lavigne Jc Fau-Desaive C.J., Desaive C.J. Cancer of the breast. A study of prognostic factors as a guide in selecting cases for conservative treatment. Acta Chir. Belg. 1975, (0001-5458 (Print).
55. Liang Y.-H., Chang C.-C., Chen C.-C., Chu-Su Y., Lin C.-W. Development of an Au/ZnO thin film surface plasmon resonance-based biosensor immunoassay for the detection of carbohydrate antigen 15-3 in human saliva. Clin. Biochem. 2012, 45(18):1689-1693.
56. Liberman M., Sampalis F., Mulder D., Sampalis J. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res. Treat. 2003, 80(1):115-126.
57. Lippman M. Hormone dependent human breast-cancer in tissue-culture. Clin. Res. 1975, 23(3). (A425-A425).
58. Litton J.K., Theriault R.L. Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 2010, 15(12):1238-1247.
59. Lokate M., Peeters P.H.M., Peelen L.M., Haars G., Veldhuis W.B., van Gils C.H. Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res. 2011, 13(5).
60. Loo L., Capobianco J.A., Wu W., Gao X., Shih W.Y., Shih W.-H., Pourrezaei K., Robinson M.K., Adams G.P. Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers. Anal. Chem. 2011, 83(9):3392-3397.
61. Markopoulos A.K., Belazi M.A., Drakoulakos D. Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes. Diabet. Res. Clin. Prac. 1997, 38(3):169-172.
62. Matsuguchi M., Uno T. Molecular imprinting strategy for solvent molecules and its application for QCM-based VOC vapor sensing. Sens. Actuators B: Chem. 2006, 113(1):94-99.
63. Merrell K., Southwick K., Graves S.W., Esplin M.S., Lewis N.E., Thulin C.D. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. J. Biomol. Tech. 2004, 15(4):238-248.
64. Michaelson J., Satija S., Moore R., Weber G., Halpern E., Garland A., Kopans D.B., Hughes K. Estimates of the sizes at which breast cancers become detectable on mammographic and clinical grounds. J. Womens Imaging 2003, 5:3-10.
65. Michaelson J., Satija S., Moore R., Weber G., Halpern E., Garland A., Puri D., Kopans D.B. The pattern of breast cancer screening utilization and its consequences. Cancer: Am. Cancer Soc. 2002, 94(1):37-43.
66. Miller R.G. Breast cancer screening: can we talk?. J. Gen. Intern. Med. 2001, 16(3):206-207.
67. Nishisho T., Hata K., Nakanishi M., Morita Y., Sun-Wada G.H., Wada Y., Yasui N., Yoneda T. The a3 isoform vacuolar type H(+)-ATPase promotes distant metastasis in the mouse B16 melanoma cells. Mol. Cancer Res. 2011, 9(7):845-855.
68. O'C'Connor M., Rhodes D., Hruska C. Molecular breast imaging. Expert Rev. Anticancer Ther. 2009, 9(8):1073-1080.
69. O'sullivan C., Guilbault G. Commercial quartz crystal microbalances-theory and applications. Biosens. Bioelectron. 1999, 14(8):663-670.
70. ODLE T.G. Breast ultrasound. Radiol. Technol. 2007, 78(3):222M-242M.
71. Oeser H., Fuchs G. [Breast cancer in women as a paradigm for ageing as a hidden syncarcinogenic factor]. Dtsch. Med. Wochenschr. 1975, 100(10):451-455.
72. Onen O., Kruk P., Guldiken R., 2011. Design of Urinary Biomarker Sensor for Early Ovarian Cancer Detection. In: Proceedings of the ASME International Mechanical Engineering Congress and Exposition, American Society of Mechanical Engineers, pp. 203-204.
73. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55(2):74-108.
74. Parkin D.M., Pisani P., Ferlay J. Global cancer statistics. CA-Cancer J. Clin. 1999, 49(1):33-64.
75. Parry J., Perry K., Mortimer P., Farrington C., Waight P., Miller E. Rational programme for screening travellers for antibodies to hepatitis A virus. Lancet 1988, 331(8600):1447-1449.
76. Peres J. Mammography screening: after the storm, calls for more personalized approaches. J. Natl. Cancer Inst. 2010, 102(1):9-10.
77. Pink R., Simek J., Vondrakova J., Faber E., Michl P., Pazdera J., Indrak K. Saliva as a diagnostic medium. Biomed. Pap. 2009, 153(2):103-110.
78. Rosser R.J. Safety of sentinel lymph node dissection and significance of cytokeratin micrometastases. J. Clin. Oncol. 2001, 19(6):1882-1883.
79. Roy R., Chun J., Powell S.N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 2012, 12(1):68-78.
80. Salama O., Herrmann S., Tziknovsky A., Piura B., Meirovich M., Trakht I., Reed B., Lobel L.I., Marks R.S. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens. Biosens. Bioelectron. 2007, 22(7):1508-1516.
81. Sarvazyan A., Egorov V., Son J.S., Kaufman C.S. Cost-effective screening for breast cancer worldwide: current state and future directions. Breast Cancer: Basic Clin. Res. 2008, 1:91-99.
82. Schillaci O., Buscombe J. Breast scintigraphy today: indications and limitations. Eur. J. Nucl. Med. Mol. Imaging 2004, 31(1):S35-S45.
83. Seitz H.K., Pelucchi C., Bagnardi V., La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol. 2012, 47(3):204-212.
84. Shao Z.-M., Nguyen M. Nipple aspiration in diagnosis of breast cancer. Semin. Surg. Oncol. 2001, 20(3):175-180.
85. Siddiqi M.A., Abdullah S. An'a 'antigen capture' 'ELISA for secretory immunoglobulin A antibodies to hepatitis B surface antigen in human saliva. J. Immunol. Methods 1988, 114(1-2):207-211.
86. Smith-Warner S.A., Spiegelman D., Adami H.O., Beeson W.L., van den Brandt P.A., Folsom A.R., Fraser G.E., Freudenheim J.L., Goldbohm R.A., Graham S., Kushi L.H., Miller A.B., Rohan T.E., Speizer F.E., Toniolo P., Willett W.C., Wolk A., Zeleniuch-Jacquotte A., Hunter D.J. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int. J. Cancer 2001, 92(5):767-774.
87. Stefatić D., Riederer M., Balić M., Dandachi N., Stanzer S., Janesch B., Resel M., Ler D., Samonigg H., Bauernhofer T. Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum. Bosn. J. Basic Med. Sci./Udruzenje basicnih mediciniskih znanosti= Assoc. Basic Med. Sci. 2008, 8(3):245-250.
88. Stockton D., Davies T., Day N., McCann J. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment?. Br. Med. J. 1997, 314(7079):472.
89. Streckfus C.F., Bigler L.R. Saliva as a diagnostic fluid. Oral Dis. 2002, 8(2):69-76.
90. Streckfus C.F., Guajardo-Edwards C. The use of saliva protein profiling as a biometric tool to determine the presence of carcinoma among women. Biometrics 2011.
91. Tadwalkar R.V., Rapelyea J.A., Torrente J., Rechtman L.R., Teal C.B., Mcswain A.P., Donnelly C., Kidwell A.B., Coffey C.M., Brem R.F. Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade. Br. J. Radiol. 2012, 85(1014):e212-e216.
92. Tainsky M.A. Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim. et Biophys. Acta 2009, 1796(2):176-193.
93. Teisner B., Davey M.W., Grudzinskas J.G. Interaction between heparin and plasma-proteins analyzed by crossed immunoelectrophoresis and affinity-chromatography. Clin. Chim. Acta 1983, 127(3):413-417.
94. Thévenot D.R., Toth K., Durst R.A., Wilson G.S. Electrochemical biosensors: recommended definitions and classification. Biosens. Bioelectron. 2001, 16(1):121-131.
95. Thieme T., Yoshihara P., Piacentini S., Beller M. Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis. J. Clin. Microbiol. 1992, 30(5):1076-1079.
96. Tiberti C., Shashaj B., Verrienti A., Vecci E.G., Lucantoni F., Masotti D., Morano S., Sulli N., Dotta F. GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva. Clin. Immunol. 2009, 131(2):271-276.
97. Tigli O., Bivona L., Berg P., Zaghloul M.E. Fabrication and characterization of a surface-acoustic-wave biosensor in CMOS technology for cancer biomarker detection. IEEE Trans. Biomed. Circ. Syst. 2010, 4(1):62-73.
98. Tiwari A., Gong S. Electrochemical detection of a breast cancer susceptible gene using cDNA immobilized chitosan-< i> co-polyaniline electrode. Talanta 2009, 77(3):1217-1222.
99. Vagdama P. Microfluidic Applications for Biosensors 2004, Queen Mary University of London, Business Briefing, Pharmatech.
100. Van Hove J.L., Zhang W., Kahler S.G., Roe C.R., Chen Y.T., Terada N., Chace D.H., Iafolla A.K., Ding J.H., Millington D.S. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am. J. Hum. Genet. 1993, 52(5):958-966.
101. Van Phuc P., Khuong T.T.T., Le Van Dong T.D.K., Tung T. Isolation and characterization of breast cancer stem cells from malignant tumours in Vietnamese women. J. Cell. Anim. Biol. 2010, 4:163-169.
102. Vo-Dinh T., Cullum B. Biosensors and biochips: advances in biological and medical diagnostics. Fresenius J. Anal. Chem. 2000, 366(6-7):540-551.
103. Wang J. Electrochemical glucose biosensors. Chem. Rev. 2008, 108(2):814.
104. Wang L. Mammography and beyond: building better breast cancer screening tests. J. Natl. Cancer Inst. 2003, 95(5):344-346.
105. Warnakulasuriya S., Soussi T., Maher R., Johnson N., Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J. Pathol. 2000, 192(1):52-57.
106. Wijesuriya D., Breslin K., Anderson G., Shriver-Lake L., Ligler F.S. Regeneration of immobilized antibodies on fiber optic probes. Biosens. Bioelectron. 1994, 9(8):585-592.
107. Zhang L., Farrell J.J., Zhou H., Elashoff D., Akin D., Park N.H., Chia D., Wong D.T. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010, 138(3):949-957. (e947).
108. Zhang L., Xiao H., Karlan S., Zhou H., Gross J., Elashoff D., Akin D., Yan X., Chia D., Karlan B., Wong D.T. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PloS One 2010, 5(12):e15573.
109. Zhou Y., Zeng Y., Huang S., Xie Q., Fu Y., Tan L., Ma M., Yao S. Quartz crystal microbalance monitoring of intervention of doxorubicin-loaded core-shell magnetic silica nanospheres on human breast cancer cells (MCF-7). Sens. Actuators B: Chem. 2012, 173(0):433-440.
110. Zhu Y., Chandra P., Shim Y.-B. Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-au nanoparticle-aptamer bioconjugate. Anal. Chem.y 2012, 85(2):1058-1064.